Cargando…
JAK2V617F阳性转CALR基因突变阳性血小板增多症一例
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348395/ https://www.ncbi.nlm.nih.gov/pubmed/28219223 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.01.008 |
| _version_ | 1783556815346204672 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7348395 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73483952020-07-16 JAK2V617F阳性转CALR基因突变阳性血小板增多症一例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2017-01 /pmc/articles/PMC7348395/ /pubmed/28219223 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.01.008 Text en 2017年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
| spellingShingle | 病例报告 JAK2V617F阳性转CALR基因突变阳性血小板增多症一例 |
| title | JAK2V617F阳性转CALR基因突变阳性血小板增多症一例 |
| title_full | JAK2V617F阳性转CALR基因突变阳性血小板增多症一例 |
| title_fullStr | JAK2V617F阳性转CALR基因突变阳性血小板增多症一例 |
| title_full_unstemmed | JAK2V617F阳性转CALR基因突变阳性血小板增多症一例 |
| title_short | JAK2V617F阳性转CALR基因突变阳性血小板增多症一例 |
| title_sort | jak2v617f阳性转calr基因突变阳性血小板增多症一例 |
| topic | 病例报告 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348395/ https://www.ncbi.nlm.nih.gov/pubmed/28219223 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.01.008 |
| work_keys_str_mv | AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì AT jak2v617fyángxìngzhuǎncalrjīyīntūbiànyángxìngxuèxiǎobǎnzēngduōzhèngyīlì |